Polyamine deprivation stimulates natural killer cell activity in cancerous mice
- PMID: 8352521
Polyamine deprivation stimulates natural killer cell activity in cancerous mice
Abstract
It has recently been established that the total blockade of all endogenous and exogenous sources of polyamines by a drug containing polyamine deficient chow (DC-PDC+) could inhibit tumor growth in vivo and increase the antitumoral efficacy of chemotherapy drugs. We show here that polyamine deprivation obtained with DC-PDC+ not only influences tumor development via reduction of polyamine concentrations in the tumor itself but, in addition, stimulates cells of the non-specific immune system specialized in tumor cell killing. We report that mice grafted with the 3LL carcinoma present a dramatic decrease in the cytotoxic activity of their natural killer (NK) cells. When these animals are treated with DC-PDC+, their NK cell activity is completely restored to normal values. Normalization of leucocyte number and differential count was observed as well. With respect to the different components of the DC-PDC+, it was observed that the endogenous and exogenous sources of polyamines have a different degree of impact on tumor development. For example, when only polyamines from digestive sources are deprived, a weak but significant improvement in NK activity and antitumoral effects were observed, without affecting intra-tumoral polyamine concentrations. We conclude that polyamines, secreted by the tumor itself as well as absorbed through the gastrointestinal tract, could now be considered not only as autocrine growth factors but also as natural immunosuppressive factors.
Similar articles
-
In vivo, synergestic inhibition of MAT-LyLu rat prostatic adenocarcinoma growth by polyamine deprivation and low-dose cyclophosphamide.Urol Res. 1996;24(2):93-8; discussion 99. doi: 10.1007/BF00431085. Urol Res. 1996. PMID: 8740978
-
Polyamine deprivation: a new tool in cancer treatment.Anticancer Res. 1994 Mar-Apr;14(2A):443-8. Anticancer Res. 1994. PMID: 8017845
-
[The involvement of polyamines in the malignant proliferative process. The anticancer effect of polyamine deprivation].Ann Gastroenterol Hepatol (Paris). 1995 May-Jun;31(3):181-8; discussion 188-9. Ann Gastroenterol Hepatol (Paris). 1995. PMID: 7653990 French.
-
The mechanisms by which polyamines accelerate tumor spread.J Exp Clin Cancer Res. 2011 Oct 11;30(1):95. doi: 10.1186/1756-9966-30-95. J Exp Clin Cancer Res. 2011. PMID: 21988863 Free PMC article. Review.
-
Polyamine inhibitors in antimicrobial chemotherapy.J Antimicrob Chemother. 1988 Oct;22(4):403-27. doi: 10.1093/jac/22.4.403. J Antimicrob Chemother. 1988. PMID: 3144522 Review. No abstract available.
Cited by
-
Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency.Breast Cancer Res. 2005;7(3):R326-35. doi: 10.1186/bcr1001. Epub 2005 Feb 25. Breast Cancer Res. 2005. PMID: 15987427 Free PMC article.
-
Polyamine deprivation prevents the development of tumour-induced immune suppression.Br J Cancer. 1997;76(3):365-70. doi: 10.1038/bjc.1997.391. Br J Cancer. 1997. PMID: 9252204 Free PMC article.
-
The role of polyamine metabolism in remodeling immune responses and blocking therapy within the tumor immune microenvironment.Front Immunol. 2022 Sep 2;13:912279. doi: 10.3389/fimmu.2022.912279. eCollection 2022. Front Immunol. 2022. PMID: 36119047 Free PMC article. Review.
-
In vivo, synergestic inhibition of MAT-LyLu rat prostatic adenocarcinoma growth by polyamine deprivation and low-dose cyclophosphamide.Urol Res. 1996;24(2):93-8; discussion 99. doi: 10.1007/BF00431085. Urol Res. 1996. PMID: 8740978
-
Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer.Sci Rep. 2016 Nov 14;6:37046. doi: 10.1038/srep37046. Sci Rep. 2016. PMID: 27841323 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical